Constantin Dreher1, Tristan Anselm Kuder2, Stefan Windhaber1, Franziska König1, Daniel Paech1, Anoshirwan Tavakoli1, Regula Gnirs1, Thomas Benkert3, Heinz-Peter Schlemmer1, and Sebastian Bickelhaupt1
1Radiology, German Cancer Research Center, Heidelberg, Germany, 2Medical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany, 3Siemens Healthcare GmbH, Erlangen, Germany
Synopsis
Diffusion-Weighted
imaging (DWI) in abdominal MRI is highly valuable for oncological follow-up-investigations.
However, intrinsic limitations of the method, including susceptibility to
motion artifacts and poor signal in the retroperitoneum, are of special
importance regarding its usage in abdominal examinations. This prospective
study compared a standard EPI-DWI with an oncologically optimized prototype DWI
in 59 patients with regard to the detectability/characterization of suspicious
lesions. The study demonstrated that the oncologically optimized prototype DWI
sequence with complex averaging, motion correction between averages, rescaling
of motion corrupted averages, and background suppression, significantly
increased the reader confidence for lesion characterization/detection in
oncological abdominal MRI.
Introduction
Oncological imaging commonly includes Diffusion-Weighted Imaging
(DWI) sequences to identify and characterize suspicious lesions. However, image
quality can be challenged by the limited SNR of DWI, especially in abdominal
examinations and by motion artifacts resulting from the diaphragm, which is why
DWI of the abdominal region needs to be improved [1]. This
prospective study investigated an optimized DWI in oncological imaging for
improved detection of malignant abdominal lesions.Methods
This IRB-approved, prospective study
included 59 patients (mean age: 57 years, male/female: 22/37). Oncological follow-up
MRI-examinations of the abdomen were performed with a 1.5T MRI scanner
(MAGNETOM Aera, Siemens Healthcare GmbH, Germany) with both a standard EPI-DWI
(“routine-DWI”, b=50,900s/mm²) and an oncologically optimized prototype DWI
(“onco-DWI”) with b=0,50,900,1500s/mm² using a prototypical EPI DWI technique
including complex averaging, motion correction between
the averages, rescaling of motion corrupted averages, and background
suppression.
The following parameters were used for routine-DWI: TR=6.5 s; TE=63 ms;
FOV 450x242 mm²; matrix 134x72; resolution 3.4x3.4 mm², interpolated to 1.7x1.7
mm²; slice thickness 5 mm; bandwidth 2332 Hz/Px; b-values 50 s/mm² and 900
s/mm² with 2 and 8 averages, gradient mode 3-scan trace, 90 slices in 3 steps,
11 min. For onco-DWI: TR=7.9 s; TE=57 ms; FOV 480x270 mm²; matrix 164x92;
resolution 3x3 mm², interpolated to 1.5x1.5 mm²; slice thickness 5 mm;
bandwidth 2540 Hz/Px; b-values 0, 50, 900, 1500 s/mm² (1, 1, 16 and 18
averages); gradient mode 3D-diagonal; 90 slices in 3 steps, 15 min.
Diagnostic
confidence for characterization/detection of suspicious lesions was evaluated
by two independent readers using a 5-point Likert Scale [2].
Statistics included Wilcoxon signed rank tests, interreader agreement was
analyzed by kappa-statistic (p<0.05).Results
Sixty-one lesions were detected (20 hepatic, 16 lymphatic,
and 25 lesions of other origins). Reader confidence for
characterization/detection of malignant lesions was significantly improved
using the onco-DWI (4.6±0.5) as compared to the routine-DWI (3.7±0.7) (p<0.001).
The increased confidence of lesion recognition in the onco-DWI remained
significant in all subgroups of hepatic, lymphatic and lesions of other origins
(p<0.002) (Figure 1 and Figure 2) with an overall good interreader agreement
(kappa = 0.744) (p<0.001).Discussion
This
prospective study demonstrated the potential of an oncologically optimized DWI
with regard to lesion detection and characterization. To date, DWI MRI is
already a highly valuable tool in oncological staging examinations. However,
compared to standard DWI the optimization of the DWI sequence significantly
improved the reader confidence in lesion detection and characterization by
providing an improved image resolution, motion correction between the averages
and complex averaging, which is why DWI optimization for the specific purposes
such as oncologic imaging [3] should be investigated in future
studies.Conclusion
The oncologically optimized body diffusion
prototype sequence with an improved image resolution, motion correction between
the averages and background suppression increased the reader confidence for
lesion characterization/detection in oncological abdominal MRI. This was
achieved both with regard to screening and follow-up examinations while
preserving a high interreader agreement with only limited extra time needed for
the examination. Optimization of DWI specifications with regard to the clinical
task should therefore be considered for future studies.Acknowledgements
Special acknowledgments and thanks to Siemens
Healthineers for providing the optimized protoype sequence and protocol.References
1. Taron, J., et al., Clinical Robustness of Accelerated and
Optimized Abdominal Diffusion-Weighted Imaging. Invest Radiol, 2017. 52(10): p. 590-595.
2. de Winter,
J.C.F., Dodou, D., Five-point Likert
items: T test versus Mann–Whitney–Wilcoxon. Practical Assessment, Research
& Evaluation, 2010. 15(11): p.
16.
3. Zhang, T.T., et
al., Differentiation of pancreatic
carcinoma and mass-forming focal pancreatitis: qualitative and quantitative
assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted
imaging. Oncotarget, 2017. 8(1):
p. 1744-1759.